Registration
09.45 - 10.20
Welcome
Ignacio Melero
10.20 - 10.30
Session 1
Chair Pedro Berraondo López
Opening Keynote Lecture: “Understanding and exploiting immunogenic cell death”
Guido Kroemer- Centre de Recherche des Cordeliers, France.
10.30 - 10.50
“Microbiota and cancer immunotherapy”
Laurence Zitvogel- Institut Gustave Roussy, France.
11.00 - 11.20
“Cancer Immunotherapy: Teaching old dogs new tricks”
Ignacio Melero Bermejo – CIMA / CUN, Spain
11.30 – 11.50
Session 2
Chair María Rodríguez Ruiz
“Targeting cancer related immune suppression by vaccination”
Inge Marie Svane- National Center for Cancer Immunotherapy, Denmark
12.00- 12.20
“Immune synapses as immunotherapy targets”
Michael Dustin- University of Oxford, UK
12.30 - 12.50
“New targetable immunosuppressive factors”.
Marisol Soengas- CNIO, Spain
13.00 - 13.20
Buffet type LUNCH
13.30 - 15.00
Session 3
Chair Antonio González
“Colon cancer immunotherapy”
Luis Diaz- Memorial Sloan Kettering Cancer Center, USA
15.00 - 15.20
“Neoadjuvant immunotherapy for MSI colon cancer”
Myriam Chalabi- Netherlands Cancer Institute, Netherlands
15.30 - 15.50
“Neoadjuvant immunotherapy of lung cancer “
Mariano Provencio- IDIPHIM, Spain
16.00 - 16.20
Session 4
Chair Miguel F. Sanmamed
“The myeloid tumor microenvironment: opportunities for intervention”
Miriam Merad- Icahn School of Medicine at Mount Sinai, USA
17.00 - 17.20
“Immunosuppressive cytokines in cancer immunology and immunotherapy”
Joan Seoane- VHIO, Spain
17.30 - 17.50
“How industry and academia should collaborate”
Antoni Ribas- UCLA, USA
18.00 - 18.20
“Improving T-Cell transfer strategies”
Sebastian Kobold- Klinikum der Universität München, Germany
18.30 - 18.50
